Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs
文献类型：期刊论文
| 作者 | Wu J(吴骏); Zhou Xing; Tan YQ(谭元卿); Wang L(王柳); Li TD(李天达); Li ZW(李仲文); Gao TT(高婷婷); Fan JQ(范佳琪); Guo BJ(郭保杰); Li W(李伟) |
| 刊名 | CELL PROLIFERATION
 |
| 出版日期 | 2020 |
| 卷号 | 53期号:12页码:e12944 |
| 源URL | [http://ir.ioz.ac.cn/handle/000000/14488]  |
| 专题 | 干细胞与生殖生物学国家重点实验室 |
| 推荐引用方式 GB/T 7714 | Wu J,Zhou Xing,Tan YQ,et al. Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs[J]. CELL PROLIFERATION,2020,53(12):e12944. |
| APA | 吴骏.,Zhou Xing.,谭元卿.,王柳.,李天达.,...&胡宝洋.(2020).Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.CELL PROLIFERATION,53(12),e12944. |
| MLA | 吴骏,et al."Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs".CELL PROLIFERATION 53.12(2020):e12944. |
入库方式： OAI收割
来源：动物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。